BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28222662)

  • 21. Methylation and expression of PTPN22 in esophageal squamous cell carcinoma.
    Deng J; Zhang J; Wang Ch; Wei Q; Zhou D; Zhao K
    Oncotarget; 2016 Sep; 7(39):64043-64052. PubMed ID: 27613842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromosomal instability associated with global DNA hypomethylation is associated with the initiation and progression of esophageal squamous cell carcinoma.
    Kawano H; Saeki H; Kitao H; Tsuda Y; Otsu H; Ando K; Ito S; Egashira A; Oki E; Morita M; Oda Y; Maehara Y
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S696-702. PubMed ID: 24898425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant Methylation-Mediated Silencing of lncRNA MEG3 Functions as a ceRNA in Esophageal Cancer.
    Dong Z; Zhang A; Liu S; Lu F; Guo Y; Zhang G; Xu F; Shi Y; Shen S; Liang J; Guo W
    Mol Cancer Res; 2017 Jul; 15(7):800-810. PubMed ID: 28539329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased mRNA expression of transcription factor forkhead box F2 is an indicator of poor prognosis in patients with resected esophageal squamous cell carcinoma.
    Zheng YZ; Wen J; Cao X; Yang H; Luo KJ; Liu QW; Huang QY; Chen JY; Fu JH
    Mol Clin Oncol; 2015 May; 3(3):713-719. PubMed ID: 26137292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Promoter hypermethylation of RASSF1A in esophageal squamous cell carcinoma.
    Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Mori M; Croce CM
    Clin Cancer Res; 2003 Apr; 9(4):1441-5. PubMed ID: 12684417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant methylation of the TERT promoter in esophageal squamous cell carcinoma.
    Deng J; Zhou D; Zhang J; Chen Y; Wang C; Liu Y; Zhao K
    Cancer Genet; 2015 Dec; 208(12):602-9. PubMed ID: 26669682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma.
    Mandelker DL; Yamashita K; Tokumaru Y; Mimori K; Howard DL; Tanaka Y; Carvalho AL; Jiang WW; Park HL; Kim MS; Osada M; Mori M; Sidransky D
    Cancer Res; 2005 Jun; 65(11):4963-8. PubMed ID: 15930319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant methylation-mediated downregulation of long noncoding RNA LOC100130476 correlates with malignant progression of esophageal squamous cell carcinoma.
    Guo W; Dong Z; Shi Y; Liu S; Liang J; Guo Y; Guo X; Shen S; Shan B
    Dig Liver Dis; 2016 Aug; 48(8):961-9. PubMed ID: 27338851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PAX5 gene as a novel methylation marker that predicts both clinical outcome and cisplatin sensitivity in esophageal squamous cell carcinoma.
    Kurimoto K; Hayashi M; Guerrero-Preston R; Koike M; Kanda M; Hirabayashi S; Tanabe H; Takano N; Iwata N; Niwa Y; Takami H; Kobayashi D; Tanaka C; Yamada S; Nakayama G; Sugimoto H; Fujii T; Fujiwara M; Kodera Y
    Epigenetics; 2017; 12(10):865-874. PubMed ID: 29099287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Promoter hypermethylation and quantitative expression analysis of CDKN2A (p14ARF and p16INK4a) gene in esophageal squamous cell carcinoma.
    Ito S; Ohga T; Saeki H; Watanabe M; Kakeji Y; Morita M; Yamada T; Maehara Y
    Anticancer Res; 2007; 27(5A):3345-53. PubMed ID: 17970080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concordant promoter methylation of transforming growth factor-beta receptor types I and II occurs early in esophageal squamous cell carcinoma.
    Dong Z; Guo W; Guo Y; Kuang G; Yang Z
    Am J Med Sci; 2012 May; 343(5):375-81. PubMed ID: 22314103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between Vascular Endothelial Growth Factor C Expressior and Lymph Node Micrometastasis and Prognosis in Patients with pNO Esophageal Squamous Cell Carcinomas.
    Sun ZG; Liu XY; Zhang M; Wang Z
    Hepatogastroenterology; 2014 May; 61(131):671-7. PubMed ID: 26176055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Demethylation-mediated upregulation of melanoma-associated antigen-A11 correlates with malignant progression of esophageal squamous cell carcinoma.
    Gu L; Sang M; Li J; Liu F; Wu Y; Liu S; Shan B
    Dig Liver Dis; 2019 Oct; 51(10):1475-1482. PubMed ID: 31155488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aberrant methylation and decreased expression of the TGF-β/Smad target gene FBXO32 in esophageal squamous cell carcinoma.
    Guo W; Zhang M; Shen S; Guo Y; Kuang G; Yang Z; Dong Z
    Cancer; 2014 Aug; 120(16):2412-23. PubMed ID: 24798237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-risk human papillomavirus infection associated with telomere elongation in patients with esophageal squamous cell carcinoma with poor prognosis.
    Zhang DH; Chen JY; Hong CQ; Yi DQ; Wang F; Cui W
    Cancer; 2014 Sep; 120(17):2673-83. PubMed ID: 24840723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypermethylation-modulated downregulation of RASSF1A expression is associated with the progression of esophageal cancer.
    Mao WM; Li P; Zheng QQ; Wang CC; Ge MH; Hu FJ; Fang XH; Dong ZM; Ling ZQ
    Arch Med Res; 2011 Apr; 42(3):182-8. PubMed ID: 21722812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Methylation of p16 and hMLH1 genes in esophageal squamous cell carcinoma and reflux esophagitis].
    Wang F; Xie XJ; Piao YS; Liu B; Wang LD
    Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):537-41. PubMed ID: 22169643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
    Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
    J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA methylation profiling of esophageal adenocarcinoma using Methylation Ligation-dependent Macroarray (MLM).
    Guilleret I; Losi L; Chelbi ST; Fonda S; Bougel S; Saponaro S; Gozzi G; Alberti L; Braunschweig R; Benhattar J
    Biochem Biophys Res Commun; 2016 Oct; 479(2):231-237. PubMed ID: 27634218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced acetylated histone H4 is associated with promoter methylation of the fragile histidine triad gene in resected esophageal squamous cell carcinoma.
    Tzao C; Sun GH; Tung HJ; Hsu HS; Hsu WH; Wang YC; Cheng YL; Lee SC
    Ann Thorac Surg; 2006 Aug; 82(2):396-401; discussion 401. PubMed ID: 16863736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.